Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014324

Burnett Patrick sold 6,287 shares at an average $25.18 ($158,320)

  • Burnett Patrick acquired 46,750 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Burnett Patrick

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-18 Grant or award : show line 1 in the form 10b5-1 +16,750 97,401 D
2026-02-27 Grant or award : show line 2 in the form 10b5-1 +30,000 127,401 D
2026-03-02 Sale : show line 3 in the form 10b5-1 −6,106 $25.16 $153,629 121,295 D
2026-03-02 Sale : show line 4 in the form 10b5-1 −181 $25.91 $4,690 121,150 D
Open-market sales · 6,287 sh · avg $25.18 · $158,320

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-27 Grant or award : show line 5 in the form 10b5-1 Stock Option (right to buy) +77,000 77,000 D
Loading xslF345X05/wk-form4_1772588506.xml…